Matches in Nanopublications for { ?s ?p "[ Combined pharmacogenetic testing for CYP2D6 and CYP2C19 identifies patients with low risk for side effects in amitriptyline therapy and could possibly be used to individualize antidepressive regimens and reduce treatment cost. Identification of genotypes]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP55054.RAS6_2KpG8huQ1N_IupaQE6_I5XAIHYUTy9MGm9hwnD90130_assertion description "[ Combined pharmacogenetic testing for CYP2D6 and CYP2C19 identifies patients with low risk for side effects in amitriptyline therapy and could possibly be used to individualize antidepressive regimens and reduce treatment cost. Identification of genotypes]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP55054.RAS6_2KpG8huQ1N_IupaQE6_I5XAIHYUTy9MGm9hwnD90130_provenance.
- NP77151.RApZXkT-yGYR9bwzQwamwhv9gBlbTxVOAYPDkcu5p7sok130_assertion description "[ Combined pharmacogenetic testing for CYP2D6 and CYP2C19 identifies patients with low risk for side effects in amitriptyline therapy and could possibly be used to individualize antidepressive regimens and reduce treatment cost. Identification of genotypes]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP77151.RApZXkT-yGYR9bwzQwamwhv9gBlbTxVOAYPDkcu5p7sok130_provenance.
- NP89434.RAjxVBkZvgXMUGJwS58P9kaO1cAIlSNZvKuL4ndfsLIo4130_assertion description "[ Combined pharmacogenetic testing for CYP2D6 and CYP2C19 identifies patients with low risk for side effects in amitriptyline therapy and could possibly be used to individualize antidepressive regimens and reduce treatment cost. Identification of genotypes]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89434.RAjxVBkZvgXMUGJwS58P9kaO1cAIlSNZvKuL4ndfsLIo4130_provenance.
- NP89435.RAJ__92yx0wbv7DQIdXW9iqsmIVMs4IbklwFDHAJlM5_w130_assertion description "[ Combined pharmacogenetic testing for CYP2D6 and CYP2C19 identifies patients with low risk for side effects in amitriptyline therapy and could possibly be used to individualize antidepressive regimens and reduce treatment cost. Identification of genotypes]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89435.RAJ__92yx0wbv7DQIdXW9iqsmIVMs4IbklwFDHAJlM5_w130_provenance.